In this review, we highlight past and recent results describing how dietary manipulation of the gut microbiota, using nutrients or specific microbes, can stimulate GLP-1 secretion in rodents and humans
Hormone replacement therapy, if its the right course of treatment for you, has the potential to set you up for success by addressing symptoms that make it easier to gain weight and harder to lose it
Genetically predicted acetyl-carnitine and cardiovascular risk factors by sex
These Ozempic-driven taste changes can include strong aversions to meat, fried foods, and even formerly favorite dishesturning once-loved meals into culinary turn-offs
Instead, it feels more like a long-term health partnership
Cardiovascular Outcomes with Orally Administered Semaglutide PIONEER 6 (NCT02692716) was an event-driven CVOT designed to confirm that treatment with orally administered semaglutide does not result in an unacceptable increase in CV risk compared with placebo